Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,200 across all filing types
Latest filing 2023-01-25 Report Publication Anno…
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of unaudited financial results for the quarter and nine months ended December 31, 2022. It mentions that the results are published as a newspaper advertisement and are also available on the company's website. The document itself is short (1224 characters) and serves as a notification or announcement about the financial results publication rather than containing the full financial report or detailed financial data. According to the 'MENU VS MEAL' rule, such a short document announcing the availability of a report is classified as a Report Publication Announcement (RPA).
2023-01-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the audio recording of an earnings call for the quarter and nine months ended December 31, 2022. It references the financial results but does not contain the financial results themselves, only a link to the recording. The document is short (1428 characters) and serves as an announcement or notification rather than the full transcript or report. According to the definitions, a full transcript of the earnings call would be classified as Call Transcript (CT), but this document only provides a link to the audio recording, not the transcript. It is not an earnings release (ER) because it does not contain key financial highlights. It is not a report publication announcement (RPA) because it is specifically about the audio recording of the earnings call. The best fit is Regulatory Filings (RNS) as a general regulatory announcement about the earnings call recording availability.
2023-01-25 English
Financial Result Updates
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of unaudited financial results for the quarter and nine months ended December 31, 2022, including consolidated revenues, EBITDA, PAT, and segment-wise performance. It includes extensive financial data, management commentary on performance, and outlook. The document is not merely a brief earnings highlight but contains substantive financial data and analysis for a period shorter than a full fiscal year (quarter and nine months). It is not an annual report, audit report, or a simple earnings release. The presence of detailed financial tables and management discussion aligns with the characteristics of an Interim / Quarterly Report (IR). Q3 2023
2023-01-24 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 95% confidence The document is a letter addressed to stock exchanges announcing the grant of stock options under the company's ESOP plan. It details the number of options granted, exercise price, vesting period, and exercisability. This is a notification about a share-based compensation event, specifically the granting of stock options, which relates to changes in share capital or equity compensation plans. The document is short (1226 characters) and is an announcement rather than a detailed report or financial statement. Therefore, it fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues or capital changes such as stock options.
2023-01-24 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of unaudited financial results for the quarter and nine months ended December 31, 2022, including consolidated financial highlights, management commentary, and market-wise performance. It includes actual financial data such as revenues, EBITDA, gross margins, and profit figures, as well as detailed analysis and outlook. The document is not merely a brief earnings release with key highlights but provides comprehensive financial information and management discussion. It is not an announcement of a report publication or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2023
2023-01-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is a notification about an upcoming earnings call to discuss the un-audited financial results for the quarter and nine months ended December 31, 2022. It includes details about the date, time, dial-in numbers, and mentions that the audio and transcript will be uploaded on the company's website. The document itself is not the earnings release or the transcript but an announcement of the earnings call event. The document length is 2561 characters, which is relatively short and consistent with an announcement rather than a full report or transcript. Therefore, the appropriate classification is Call Transcript (CT) because it is an invitation and information about the earnings call, which is typically classified under CT as it relates to the conference call event and transcript availability.
2023-01-23 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.